A new paper test for early detection of colorectal cancer.
Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening
This study is working on a simple and affordable paper test that can help people check for early signs of colorectal cancer at home, making it easier for those who might not usually get screened to take charge of their health.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10757644 on NIH RePORTER |
What this research studies
This research aims to develop a simple and cost-effective paper-based blood test that can detect early-stage colorectal cancer (CRC) biomarkers. The approach involves using a 3D microfluidic device to multiplex the detection of five specific cancer antigens, which could allow for self-testing at home. Patients would send their samples to a central facility for analysis, potentially increasing screening rates among underserved populations. The goal is to improve accessibility and accuracy in CRC screening, particularly for those who may not have regular access to healthcare.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for colorectal cancer, particularly those from minority, uninsured, or low-income backgrounds.
Not a fit: Patients who are not at risk for colorectal cancer or those who have already been diagnosed with advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more accessible and accurate method for early detection of colorectal cancer, potentially saving lives.
How similar studies have performed: Other research has shown promise in developing similar diagnostic approaches, but this specific method is novel and untested.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Badu-Tawiah, Abraham — Ohio State University
- Study coordinator: Badu-Tawiah, Abraham
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.